Download Docs
Export

OCHAPSIS

50220122 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Nov. 16, 2026
Serial No. 50220122
Examining Attorney null
Class Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease; Pharmaceutical preparations for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD); Pharmaceutical preparations for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease; Pharmaceutical preparations for the treatment of portopulmonary hypertension; Pharmaceutical preparations for the treatment of pulmonary hypertension associated with sleep-related breathing disorders; Pharmaceutical preparations for the treatment of pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders; 005; 006; 018; 044; 046; 051; 052
OCHAPSIS
Case Type Trademark
Status New application awaiting assignment to an examining attorney. <a href="https://www.uspto.gov/dashboard/trademarks/application-timeline.html">See current trademark processing wait times </a> for more information.
Last Updated: 1 day, 9 hours ago
Filing Date # Docket Text
to view the full docket.